SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (CERO) (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results